{"id":"placebo-males","safety":{"commonSideEffects":[{"rate":null,"effect":"Placebo response (perceived symptom improvement without active drug)"}]},"_chembl":{"chemblId":"CHEMBL1256686","moleculeType":"Small molecule","molecularWeight":"523.63"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inactive substance administered in controlled clinical studies to establish baseline efficacy and safety by comparison with active drug. Any observed clinical benefit from placebo is attributed to psychological factors, natural disease progression, or regression to the mean rather than direct pharmacological action. Placebos are essential for blinded trial design to isolate true drug effects from expectancy and observer bias.","oneSentence":"Placebo produces no pharmacological effect, serving as an inert control in clinical trials to measure the placebo response.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:05.833Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clinical trial control arm (not a therapeutic indication)"}]},"trialDetails":[{"nctId":"NCT07497113","phase":"NA","title":"The Effects of Commercially Available High Protein Drink on Amino Acid Bioavailability and Recovery From Muscle Fatiguing Exercise in 18-45-year-old Male and Female Participants.","status":"COMPLETED","sponsor":"Anglia Ruskin University","startDate":"2025-03-01","conditions":"Healthy Participants","enrollment":62},{"nctId":"NCT03049462","phase":"PHASE1","title":"The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2017-03-13","conditions":"Polycystic Ovary Syndrome","enrollment":100},{"nctId":"NCT07497685","phase":"NA","title":"Effects of Different Caffeine Forms on Aerobic and Anaerobic Exercise Performance","status":"COMPLETED","sponsor":"University of Gaziantep","startDate":"2024-10-10","conditions":"Exercise Performance, Physical Performance","enrollment":14},{"nctId":"NCT07050316","phase":"PHASE1","title":"Intranasal Administration of Dodecyl Creatine Ester (CBT101) in Healthy Male Subjects","status":"COMPLETED","sponsor":"Ceres Brain Therapeutics","startDate":"2025-03-14","conditions":"Neurologic Diseases, General","enrollment":48},{"nctId":"NCT07209462","phase":"PHASE2","title":"Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)","status":"RECRUITING","sponsor":"Mirum Pharmaceuticals, Inc.","startDate":"2025-11-22","conditions":"Fragile X Syndrome","enrollment":60},{"nctId":"NCT07250048","phase":"PHASE1","title":"A Study in Healthy Men to Find Out How Different Doses of BI 3009947 Are Tolerated and How Different Formulations or Food Influence How BI 3009947 is Taken up Into the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2025-11-21","conditions":"Healthy","enrollment":40},{"nctId":"NCT07491458","phase":"PHASE2","title":"A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)","status":"RECRUITING","sponsor":"Rivus Pharmaceuticals, Inc.","startDate":"2026-02-13","conditions":"MASH - Metabolic Dysfunction-Associated Steatohepatitis","enrollment":180},{"nctId":"NCT07075640","phase":"PHASE1","title":"A Study to Determine the Safety and Tolerability of AG-236 and How it is Absorbed, Broken Down, and Eliminated From the Body in Healthy Participants","status":"RECRUITING","sponsor":"Agios Pharmaceuticals, Inc.","startDate":"2025-07-07","conditions":"Healthy Participants","enrollment":24},{"nctId":"NCT07486115","phase":"PHASE1","title":"A Study to Test How Different Doses of BI 3814916 Are Tolerated by Healthy People","status":"NOT_YET_RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2026-04-07","conditions":"Healthy","enrollment":136},{"nctId":"NCT06984926","phase":"PHASE1","title":"A Study to Test How Well Multiple Doses of BI 3810477 Are Tolerated by Healthy Adults","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2025-06-06","conditions":"Healthy","enrollment":47},{"nctId":"NCT07435012","phase":"PHASE3","title":"Androgenic Alopecia TH07 Clinical Trial","status":"RECRUITING","sponsor":"Triple Hair Inc","startDate":"2026-04","conditions":"Androgenic Alopecia","enrollment":420},{"nctId":"NCT07466732","phase":"EARLY_PHASE1","title":"Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males","status":"ENROLLING_BY_INVITATION","sponsor":"Liverpool John Moores University","startDate":"2025-12-08","conditions":"Caffeine, Placebo - Control, No Pill","enrollment":15},{"nctId":"NCT06200467","phase":"PHASE1","title":"A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-03-13","conditions":"Overweight, Obesity","enrollment":110},{"nctId":"NCT05925803","phase":"PHASE3","title":"Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2023-11-08","conditions":"Systemic Sclerosis, Scleroderma","enrollment":314},{"nctId":"NCT07469852","phase":"PHASE1, PHASE2","title":"Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in Males","status":"ACTIVE_NOT_RECRUITING","sponsor":"Liverpool John Moores University","startDate":"2026-01-12","conditions":"Caffeine, Placebo - Control, No Pill","enrollment":15},{"nctId":"NCT07466628","phase":"PHASE4","title":"Effects of Caffeine Ingestion on Morning Cognitive and Muscle Strength Measures in Males","status":"COMPLETED","sponsor":"Liverpool John Moores University","startDate":"2024-11-15","conditions":"Caffine, Placebo - Control, No Pill","enrollment":15},{"nctId":"NCT06382948","phase":"PHASE3","title":"Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.","status":"RECRUITING","sponsor":"MedSIR","startDate":"2024-12-05","conditions":"Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer","enrollment":240},{"nctId":"NCT07466030","phase":"PHASE1","title":"Tadalafil 5 mg on Storage Lower Urinary Tract Symptoms After Anatomical Endoscopic Enucleation of the Prostate","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-03-01","conditions":"BPH (Benign Prostatic Hyperplasia)","enrollment":40},{"nctId":"NCT06641089","phase":"PHASE3","title":"Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response","status":"RECRUITING","sponsor":"MoonLake Immunotherapeutics AG","startDate":"2024-10-15","conditions":"Arthritis, Psoriatic","enrollment":600},{"nctId":"NCT07404449","phase":"PHASE1","title":"Sex-Speciffic Longevity Food Supplements","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Primorska","startDate":"2026-03-07","conditions":"Aging","enrollment":60},{"nctId":"NCT07118891","phase":"PHASE1, PHASE2","title":"Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause","status":"RECRUITING","sponsor":"AbCellera Biologics Inc.","startDate":"2025-06-23","conditions":"Vasomotor Symptoms Associated With Menopause, Healthy Volunteers","enrollment":136},{"nctId":"NCT07327359","phase":"PHASE1, PHASE2","title":"A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia","status":"RECRUITING","sponsor":"Olix Pharmaceuticals, Inc.","startDate":"2025-12-04","conditions":"Androgenetic Alopecia (AGA)","enrollment":158},{"nctId":"NCT05318534","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease","status":"RECRUITING","sponsor":"Gliknik Inc.","startDate":"2022-04-08","conditions":"First in Man Study to Evaluate Initial Safety","enrollment":70},{"nctId":"NCT07454265","phase":"NA","title":"Short-Term Broccoli Supplementation and Acute Oxidative Stress Recovery","status":"COMPLETED","sponsor":"Lithuanian Sports University","startDate":"2024-11-30","conditions":"Healthy Adult Male","enrollment":17},{"nctId":"NCT07450521","phase":"PHASE1","title":"Evaluation of MTX-463 Administered Subcutaneously in Healthy Adult Males","status":"RECRUITING","sponsor":"Mediar Therapeutics","startDate":"2026-02-18","conditions":"Healthy Adult Male","enrollment":8},{"nctId":"NCT05726292","phase":"PHASE2","title":"A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-01-06","conditions":"Prostate Cancer, Prostate Adenocarcinoma","enrollment":90},{"nctId":"NCT05681299","phase":"PHASE4","title":"Effects of GH and Lirglutide on AgRP","status":"RECRUITING","sponsor":"Columbia University","startDate":"2023-05-01","conditions":"Healthy, Growth Hormone Deficiency","enrollment":40},{"nctId":"NCT07076706","phase":"PHASE2","title":"Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia","status":"COMPLETED","sponsor":"Beijing Dayspring Pharmaceutical Technology Co., Ltd","startDate":"2024-12-05","conditions":"Male Pattern of Hair Loss, Androgenic Alopecia, Androgenetic Alopecia (AGA)","enrollment":110},{"nctId":"NCT07160634","phase":"PHASE3","title":"A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)","status":"RECRUITING","sponsor":"Solid Biosciences Inc.","startDate":"2025-10-22","conditions":"Duchenne Muscular Dystrophy","enrollment":80},{"nctId":"NCT05039515","phase":"PHASE2","title":"A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Clementia Pharmaceuticals Inc.","startDate":"2021-12-01","conditions":"Fibrodysplasia Ossificans Progressiva","enrollment":113},{"nctId":"NCT06331884","phase":"PHASE1","title":"Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)","status":"COMPLETED","sponsor":"4TEEN4 Pharmaceuticals GmbH","startDate":"2024-03-07","conditions":"Safety and Tolerability, Healthy Volunteers","enrollment":24},{"nctId":"NCT07439510","phase":"PHASE2, PHASE3","title":"A Study to Investigate the Effects and Safety of SPG601 for the Treatment of Fragile X Syndrome in Male Participants","status":"NOT_YET_RECRUITING","sponsor":"Spinogenix","startDate":"2026-03-01","conditions":"Fragile X Syndrome (FXS)","enrollment":248},{"nctId":"NCT06641076","phase":"PHASE3","title":"Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug","status":"ACTIVE_NOT_RECRUITING","sponsor":"MoonLake Immunotherapeutics AG","startDate":"2024-10-15","conditions":"Arthritis, Psoriatic","enrollment":960},{"nctId":"NCT05583955","phase":"PHASE2","title":"A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)","status":"COMPLETED","sponsor":"Noema Pharma AG","startDate":"2022-07-25","conditions":"Childhood-Onset Fluency Disorder","enrollment":75},{"nctId":"NCT07289776","phase":"PHASE1","title":"A First-in-human Trial of GRT7041 in Healthy Participants","status":"RECRUITING","sponsor":"Grünenthal GmbH","startDate":"2026-01-14","conditions":"Treatment of Pain","enrollment":70},{"nctId":"NCT04546009","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2020-10-09","conditions":"Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer","enrollment":992},{"nctId":"NCT05759468","phase":"PHASE2","title":"NAD Augmentation in Diabetes Kidney Disease","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2023-04-13","conditions":"Type2diabetes, Diabetic Kidney Disease","enrollment":140},{"nctId":"NCT07060508","phase":"PHASE2","title":"L9LS in Women of Childbearing Potential in Mali","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-07-22","conditions":"Malaria","enrollment":290},{"nctId":"NCT06916702","phase":"PHASE1","title":"A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men","status":"RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2025-04-07","conditions":"Healthy","enrollment":60},{"nctId":"NCT06972264","phase":"PHASE3","title":"Safety and Efficacy of VDPHL01 in Males With AGA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Veradermics, Inc.","startDate":"2025-03-11","conditions":"Androgenetic Alopecia, AGA, Male Pattern Baldness","enrollment":480},{"nctId":"NCT07407543","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males","status":"RECRUITING","sponsor":"siRNAgen Therapeutics Inc.","startDate":"2026-01-05","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":30},{"nctId":"NCT07407634","phase":"EARLY_PHASE1","title":"A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.","status":"NOT_YET_RECRUITING","sponsor":"Xi'an Xintong Pharmaceutical Research Co.,Ltd.","startDate":"2026-03-25","conditions":"Non-Alcoholic Fatty Liver Disease","enrollment":94},{"nctId":"NCT01674140","phase":"PHASE3","title":"S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2013-09-12","conditions":"Breast Cancer","enrollment":1939},{"nctId":"NCT06300307","phase":"PHASE1, PHASE2","title":"Study of ATX-01 in Participants With DM1","status":"RECRUITING","sponsor":"ARTHEx Biotech S.L.","startDate":"2024-10-15","conditions":"Myotonic Dystrophy 1","enrollment":56},{"nctId":"NCT07396857","phase":"NA","title":"The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting","status":"RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2025-11-01","conditions":"Cardiovascular","enrollment":40},{"nctId":"NCT07393334","phase":"PHASE2","title":"Effects of NLS-133, a Potential Non-Hormonal \"On-Demand\" Male Contraceptive","status":"RECRUITING","sponsor":"Next Life Sciences","startDate":"2025-12-02","conditions":"Male Contraception, Semen Volume, Sperm Motility","enrollment":10},{"nctId":"NCT05579327","phase":"PHASE3","title":"Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)","status":"COMPLETED","sponsor":"Rare Thyroid Therapeutics International AB","startDate":"2023-07-21","conditions":"Monocarboxylate Transporter 8 Deficiency, Allan-Herndon-Dudley Syndrome","enrollment":20},{"nctId":"NCT07225777","phase":"PHASE2","title":"Sex Differences in Neurobehavioral Response to THC","status":"NOT_YET_RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2026-04-01","conditions":"Cannabis Use Disorder","enrollment":40},{"nctId":"NCT07189442","phase":"NA","title":"L-theanine and Paraxanthine for Cognitive Improvement in Adults With ADHD and ASD","status":"RECRUITING","sponsor":"Texas Tech University Health Sciences Center","startDate":"2025-10-01","conditions":"Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD)","enrollment":24},{"nctId":"NCT07389837","phase":"NA","title":"Maple Syrup Carbohydrate Dose-Response on 20-km Cycling Time-Trial Performance","status":"NOT_YET_RECRUITING","sponsor":"Université de Montréal","startDate":"2026-02-01","conditions":"Exercise, Endurance Cycling Performance, Carbohydrate Intolerance","enrollment":32},{"nctId":"NCT05163808","phase":"PHASE2, PHASE3","title":"A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome","status":"COMPLETED","sponsor":"Tetra Discovery Partners","startDate":"2022-03-29","conditions":"Fragile X Syndrome","enrollment":163},{"nctId":"NCT05206773","phase":"PHASE3","title":"A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2022-03-11","conditions":"Fabry Disease","enrollment":122},{"nctId":"NCT07386210","phase":"NA","title":"Antihypertensive Effects of Rosmarinus Officinalis L. Infusion","status":"COMPLETED","sponsor":"awatef Sassi","startDate":"2023-03-20","conditions":"Hypertension Arterial","enrollment":54},{"nctId":"NCT07016464","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants.","status":"TERMINATED","sponsor":"reMYND","startDate":"2025-03-20","conditions":"Healthy","enrollment":19},{"nctId":"NCT07377539","phase":"PHASE1","title":"A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy Participants","status":"NOT_YET_RECRUITING","sponsor":"Jazz Pharmaceuticals","startDate":"2026-02-03","conditions":"Healthy Participants","enrollment":86},{"nctId":"NCT05697640","phase":"PHASE2","title":"Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2023-06-22","conditions":"Post-COVID ME/CFS","enrollment":104},{"nctId":"NCT07373106","phase":"NA","title":"Short-term Effects of Broccoli-derived Glucoraphanin on Recovery From Eccentric Muscle Damage","status":"NOT_YET_RECRUITING","sponsor":"Lithuanian Sports University","startDate":"2026-02-15","conditions":"Healthy","enrollment":17},{"nctId":"NCT06248619","phase":"PHASE3","title":"A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Amgen","startDate":"2024-07-05","conditions":"Thyroid Eye Disease","enrollment":89},{"nctId":"NCT07369908","phase":"NA","title":"The Effects of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Anxiety Responses and Emotional Regulation","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2025-10-09","conditions":"Healthy Male and Female Volunteers","enrollment":140},{"nctId":"NCT07371052","phase":"NA","title":"Olive Leaf Extract in Handball Players","status":"COMPLETED","sponsor":"Karabuk University","startDate":"2025-01-01","conditions":"Handball Players","enrollment":18},{"nctId":"NCT04002661","phase":"PHASE2","title":"Hypoactive Sexual Desire Disorder in Males","status":"TERMINATED","sponsor":"Mohit Khera","startDate":"2020-05-08","conditions":"Low Libido","enrollment":8},{"nctId":"NCT06381466","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Healthy Adult Participants.","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2024-04-01","conditions":"Dilated Cardiomyopathy","enrollment":84},{"nctId":"NCT06049095","phase":"PHASE1","title":"A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants","status":"RECRUITING","sponsor":"Latigo Biotherapeutics","startDate":"2023-10-17","conditions":"Healthy","enrollment":204},{"nctId":"NCT07110610","phase":"PHASE1","title":"Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants","status":"RECRUITING","sponsor":"Latigo Biotherapeutics","startDate":"2025-09-03","conditions":"Healthy Participants","enrollment":236},{"nctId":"NCT07250230","phase":"NA","title":"Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Undergoing Thoracic Surgery: A Randomized Controlled Pilot Study","status":"RECRUITING","sponsor":"Henan Provincial People's Hospital","startDate":"2025-11-30","conditions":"Nicotine Dependence, Thoracic Diseases, Analgesia","enrollment":80},{"nctId":"NCT06687967","phase":"PHASE3","title":"A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-11-28","conditions":"Lichen Simplex Chronicus","enrollment":142},{"nctId":"NCT06687980","phase":"PHASE3","title":"A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-11-25","conditions":"Lichen Simplex Chronicus","enrollment":138},{"nctId":"NCT06143059","phase":"PHASE3","title":"The Effects of Sex Hormones and Alcohol on Sleep","status":"SUSPENDED","sponsor":"Lauren Whitehurst","startDate":"2024-01-08","conditions":"Alcohol Use Disorder","enrollment":130},{"nctId":"NCT06305182","phase":"PHASE2","title":"Metreleptin in Anorexia Nervosa","status":"RECRUITING","sponsor":"Gabriella Milos","startDate":"2024-05-31","conditions":"Anorexia Nervosa","enrollment":50},{"nctId":"NCT07345455","phase":"NA","title":"Probiotics on Sperm Quality in Male Infertility Patients","status":"RECRUITING","sponsor":"Mackay Memorial Hospital","startDate":"2023-09-16","conditions":"Male Infertility, Oligozoospermia, Asthenozoospermia","enrollment":60},{"nctId":"NCT06122038","phase":"NA","title":"Impact of Powdered Tart Cherries on Recovery From Repeated Sprints","status":"COMPLETED","sponsor":"Lindenwood University","startDate":"2023-04-25","conditions":"Inflammation, Oxidative Stress, Soreness, Muscle","enrollment":40},{"nctId":"NCT07337265","phase":"NA","title":"Royal Jelly Supplementation in Unexplained Male Infertility","status":"NOT_YET_RECRUITING","sponsor":"Medipol University","startDate":"2026-02-01","conditions":"Unexplained Infertility, Male Infertility, Sperm DNA Fragmentation","enrollment":80},{"nctId":"NCT07333443","phase":"NA","title":"Caffeine and Sport Climbing Performance","status":"COMPLETED","sponsor":"University of Alcala","startDate":"2025-01-08","conditions":"Climbing, Caffeine","enrollment":13},{"nctId":"NCT06130449","phase":"EARLY_PHASE1","title":"Testosterone and Neural Function","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-04-01","conditions":"Spinal Cord Injury","enrollment":15},{"nctId":"NCT05076422","phase":"PHASE1","title":"A Study to Test How Well Men Tolerate Different Doses of BI 3006337","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2021-10-18","conditions":"Healthy","enrollment":80},{"nctId":"NCT04481750","phase":"PHASE1","title":"Study of Oral Edaravone in Healthy Adult Males","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2018-03-20","conditions":"Healthy Adult Subjects","enrollment":74},{"nctId":"NCT06866275","phase":"PHASE2","title":"Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD)","status":"RECRUITING","sponsor":"Children's Hospital of Orange County","startDate":"2025-04-09","conditions":"Autism Spectrum Disorder (ASD)","enrollment":45},{"nctId":"NCT07324759","phase":"NA","title":"Clinical Study to Assess Safety, Effectiveness and In-Use Tolerability of Saffron Extract Capsules for Improving Skin Health and Reducing Signs of Aging on Healthy Adult Male and Female Subjects.","status":"NOT_YET_RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2026-01-01","conditions":"Wrinkles, Fine Lines, Hyperpigmentation","enrollment":50},{"nctId":"NCT07317544","phase":"PHASE1, PHASE2","title":"Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia","status":"RECRUITING","sponsor":"Absci Pty Ltd.","startDate":"2025-12-03","conditions":"Androgenetic Alopecia (AGA), Healthy Volunteers - Male and Female","enrollment":227},{"nctId":"NCT07004322","phase":"PHASE1","title":"A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body Weight","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2025-05-26","conditions":"Diabetes Mellitus, Type 2, Obesity","enrollment":20},{"nctId":"NCT05521256","phase":"PHASE1","title":"A Research Study of a New Medicine NNC0113-6856 in Healthy Males","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2022-08-26","conditions":"Healthy Volunteers, Type 2 Diabetes","enrollment":70},{"nctId":"NCT07312604","phase":"NA","title":"A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Years With Recalcitrant Tinea Cruris and Corporis","status":"RECRUITING","sponsor":"Abeer Mohamed Abdelaziz Elkholy","startDate":"2025-12-09","conditions":"Tinea Corporis, Tinea Cruris","enrollment":50},{"nctId":"NCT07297602","phase":"PHASE2","title":"Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study","status":"RECRUITING","sponsor":"Nora Mohamed Abdelrazik","startDate":"2025-11-20","conditions":"Atopic Dermatitis","enrollment":36},{"nctId":"NCT06714825","phase":"PHASE1","title":"Study of HS235 for Assessing the Pharmacokinetics, Safety, and Pharmacodynamics in Overweight/Obese Healthy Subjects","status":"COMPLETED","sponsor":"35Pharma Inc","startDate":"2024-11-28","conditions":"Overweight and Obesity","enrollment":39},{"nctId":"NCT06899230","phase":"PHASE1","title":"Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007","status":"ACTIVE_NOT_RECRUITING","sponsor":"iQure Australia Pty Ltd","startDate":"2025-04-08","conditions":"Drug Resistant Epilepsy, Focal Seizure","enrollment":72},{"nctId":"NCT06334419","phase":"PHASE2","title":"Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS)","status":"COMPLETED","sponsor":"Craig Erickson","startDate":"2024-01-29","conditions":"Fragile X Syndrome","enrollment":10},{"nctId":"NCT04925752","phase":"PHASE3","title":"Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2021-06-28","conditions":"Pre-Exposure Prophylaxis of HIV Infection","enrollment":3292},{"nctId":"NCT06310005","phase":"PHASE1","title":"A Study in Healthy Japanese Men to Test How Well Different Doses of BI 3006337 Are Tolerated","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-04-19","conditions":"Healthy","enrollment":36},{"nctId":"NCT05838573","phase":"PHASE3","title":"Metformin Treatment on Cognitive Impairment of Schizophrenia","status":"RECRUITING","sponsor":"Central South University","startDate":"2023-05-08","conditions":"Schizophrenia","enrollment":120},{"nctId":"NCT02115282","phase":"PHASE3","title":"Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-03-29","conditions":"Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Adenocarcinoma","enrollment":608},{"nctId":"NCT06308861","phase":"PHASE1","title":"Investigate Safety, Tolerability, PK/PK of J2H 1702 in Healthy Males","status":"COMPLETED","sponsor":"J2H Biotech","startDate":"2020-08-12","conditions":"Non-alcoholic Steatohepatitis","enrollment":100},{"nctId":"NCT06894875","phase":"NA","title":"Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance","status":"RECRUITING","sponsor":"Nuritas Ltd","startDate":"2025-06-24","conditions":"Exercise, Blood Pressure, Vasodilation","enrollment":48},{"nctId":"NCT05575492","phase":"PHASE1, PHASE2","title":"A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age","status":"ACTIVE_NOT_RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2022-11-07","conditions":"Cytomegalovirus","enrollment":873},{"nctId":"NCT07281846","phase":"NA","title":"TIPS With or Without BCAA","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2025-11-15","conditions":"BCAA, Cirrhosis, Portal Hypertension Related to Cirrhosis","enrollment":164},{"nctId":"NCT05370651","phase":"NA","title":"Emsella Chair vs Sham for Male Sexual Dysfunction","status":"RECRUITING","sponsor":"Corewell Health East","startDate":"2022-12-14","conditions":"Male Sexual Dysfunction, Ejaculatory Dysfunction","enrollment":117},{"nctId":"NCT01188512","phase":"PHASE1","title":"First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2010-08","conditions":"Pertussis","enrollment":48},{"nctId":"NCT06206824","phase":"PHASE1","title":"Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease","status":"RECRUITING","sponsor":"Perha Pharmaceuticals","startDate":"2024-01-18","conditions":"Healthy Volunteers, Down Syndrome, Alzheimer's Disease","enrollment":164},{"nctId":"NCT06721091","phase":"PHASE1","title":"Safety, Tolerability, and Dose Response of VNA-318 in Healthy Males","status":"COMPLETED","sponsor":"VANDRIA","startDate":"2024-12-03","conditions":"Healthy Volunteer","enrollment":92},{"nctId":"NCT06284798","phase":"PHASE1","title":"A Research Study of a New Medicine (NNC0650-0013) in Healthy Men","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2024-01-29","conditions":"Healthy Participants","enrollment":11},{"nctId":"NCT06854575","phase":"NA","title":"A Safety and Efficacy Study of a Nutraceutical in Aging Males With Thinning Hair","status":"TERMINATED","sponsor":"Nutraceutical Wellness Inc.","startDate":"2025-03-10","conditions":"Hair Thinning","enrollment":155}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["saline physiological 5 ml"],"phase":"marketed","status":"active","brandName":"Placebo males","genericName":"Placebo males","companyName":"Ullevaal University Hospital","companyId":"ullevaal-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo produces no pharmacological effect, serving as an inert control in clinical trials to measure the placebo response. Used for Clinical trial control arm (not a therapeutic indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}